Procalcitonin in respiratory disease: use as a biomarker for diagnosis and guiding antibiotic therapy Source: Breathe, 15 (4) 296; 10.1183/20734735.0258-2019 Year: 2019
Could procalcitonin (PCT) be a marker of effectiveness of antibiotic treatment (ABT) in pregnant with not severe community-acquired pneumonia (CAP)? Source: International Congress 2015 – Healthcare organisation and appropriateness in lung disorders Year: 2015
The practice of empiric antibiotic therapy in patients with coronavirus disease 2019 (COVID-19). Source: Virtual Congress 2021 – COVID – 19: treatments and predictive factors Year: 2021
Procalcitonin to guide antibiotic administration in COPD exacerbations: a meta-analysis Source: Eur Respir Rev 2017; 26: 160073 Year: 2017
Can we use a biomarker to guide antibiotic treatment in severe COPD exacerbations? Source: Breathe, 15 (4) 353; 10.1183/20734735.0257-2019 Year: 2019
Indication for antibiotic therapy in AECB: anthonisen‘s criteria versus procalcitonin Source: Eur Respir J 2004; 24: Suppl. 48, 50s Year: 2004
Procalcitonin for reduced antibiotic exposure in ventilator-associated pneumonia: a randomised study Source: Eur Respir J 2009; 34: 1364-1375 Year: 2009
C-reactive protein (C-RP) in patients with chronic heart failure (CHF) and community-acquired pneumonia (CAP): usefulness to guide antibiotic prescription Source: International Congress 2018 – Predicting the future: biomarkers of respiratory infection Year: 2018
Changes in empirical initial antibiotic therapy in community-acquired pneumonia: assessment of clinical failure versus discordant therapy Source: Eur Respir J 2006; 28: Suppl. 50, 736s Year: 2006
Pneumonia: diagnosis, treatment and prevention Source: International Congress 2018 – State of the art session: Respiratory infections Year: 2018
Point-of-care procalcitonin test to reduce antibiotics in COPD exacerbation: A quasi-randomised control trial Source: International Congress 2015 – Infection in COPD: different aspects of the host/pathogen balance Year: 2015
Efficacy of using special software “Optimization of medication choice for treatment of patient with comorbidity” (SS) for management of patients with community-acquired pneumonia (CAP) and cardiovascular disease Source: International Congress 2019 – M-health/e-health I Year: 2019
Can procalcitonin testing reduce antibiotic prescribing for respiratory infections? Source: Annual Congress 2006 - Inflammation markers in community-acquired pneumonia Year: 2006
Individual monitoring of procalcitonin and C-reactive protein levels as a criterion for cancel of antibiotic therapy in patients with severe community-acquired pneumonia Source: Annual Congress 2013 –Biomarkers, diagnosis and outcome of respiratory infections Year: 2013
Late Breaking Abstract - Severe pneumonia patients may could not benefit from antibiotic combination therapy and non-invasive ventilation(NIV), despite the advanced mode Source: International Congress 2018 – Non-invasive ventilation for acute respiratory failure Year: 2018
Should we change our antibiotic strategy in AECOPD or CAP+COPD patients? Source: International Congress 2015 – Differentiating COPD exacerbations from pneumonia in COPD patients Year: 2015
Sputum induction for assessment of biomarkers in early development of new drugs for respiratory disease in a proof of concept setting Source: International Congress 2016 – Airway biomarkers Year: 2016
Biomarkers in respiratory tract infections: diagnostic guides to antibiotic prescription, prognostic markers and mediators Source: Eur Respir J 2007; 30: 556-573 Year: 2007
Improved diagnostics and diagnostic approaches: The role in the fight to emerging infectious diseases (EID) and antimicrobial resistance (AMR) Source: Postgraduate course 2021: PG7 - Postgraduate course : Emerging infectious diseases and antimicrobial resistance: diagnostics, treatments, vaccines and other preventive and/or therapeutic interventions Year: 2021
Efficacy of early COPD diagnosis and intervention system Source: International Congress 2014 – Physical activity, exercise and physiotherapy in patients with COPD Year: 2014